Melissa L Larson

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. ncbi request reprint HIV-related lymphoma treated with maintenance thalidomide
    Melissa L Larson
    Rush University Medical Center, Chicago, IL 60612, USA
    Clin Adv Hematol Oncol 3:231-4; discussion 234-5. 2005
  2. doi request reprint Clofarabine: a new treatment option for patients with acute myeloid leukemia
    Melissa L Larson
    Section of Hemtology, Rush University Medical Center, 1725 West Harrison, Suite 809, Chicago, IL 60612, USA
    Expert Opin Pharmacother 10:1353-7. 2009
  3. doi request reprint Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lym
    Reem Karmali
    Rush University Medical Center, Department of Hematology Oncology, Chicago, IL 60612, USA
    Leuk Lymphoma 52:2097-104. 2011
  4. doi request reprint Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia
    Reem Karmali
    a Section of Hematology Division of Hematology Oncology Cell Therapy, Chicago, IL, USA
    Leuk Lymphoma 56:3135-42. 2015
  5. pmc Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients
    Reem Karmali
    Division of Hematology Oncology Cell Therapy, Rush University Medical Center, 1725 W Harrison St, Chicago, IL 60612, USA
    J Leukoc Biol 93:161-70. 2013
  6. ncbi request reprint Posttransplant lymphoproliferative disorder: extranodal marginal zone lymphoma occurring after renal transplantation
    Justin M Goldfarb
    Section of Hematology and Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Clin Adv Hematol Oncol 4:600-4; discussion 604-6. 2006

Collaborators

  • Stephanie A Gregory
  • Sari H Enschede
  • James E Wooldridge
  • Reem Karmali
  • Parameswaran Venugopal
  • Jamile M Shammo
  • Justin M Goldfarb
  • Sanjib Basu
  • Kent Christopherson
  • Jeffrey A Borgia
  • Robin R Frank
  • Laura A Paganessi
  • Sucheta Jagan
  • Kent W Christopherson
  • Katherine Bueschel
  • Teresa O'Brien

Detail Information

Publications6

  1. ncbi request reprint HIV-related lymphoma treated with maintenance thalidomide
    Melissa L Larson
    Rush University Medical Center, Chicago, IL 60612, USA
    Clin Adv Hematol Oncol 3:231-4; discussion 234-5. 2005
  2. doi request reprint Clofarabine: a new treatment option for patients with acute myeloid leukemia
    Melissa L Larson
    Section of Hemtology, Rush University Medical Center, 1725 West Harrison, Suite 809, Chicago, IL 60612, USA
    Expert Opin Pharmacother 10:1353-7. 2009
    ..This compound seems to have efficacy in older patients, as well as those with adverse cytogenetics...
  3. doi request reprint Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy in previously untreated patients with diffuse large B-cell lymphoma and mantle cell lym
    Reem Karmali
    Rush University Medical Center, Department of Hematology Oncology, Chicago, IL 60612, USA
    Leuk Lymphoma 52:2097-104. 2011
    ..The most common toxicity was myelosuppression. Sequential combination of CHOP with GM-CSF priming and rituximab was feasible and effective, warranting further evaluation...
  4. doi request reprint Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia
    Reem Karmali
    a Section of Hematology Division of Hematology Oncology Cell Therapy, Chicago, IL, USA
    Leuk Lymphoma 56:3135-42. 2015
    ..These findings provide promising evidence that IGFBP signatures could be used as predictive tools in AML, with applications in remission surveillance and the development of IGFBP-directed biologic therapy. ..
  5. pmc Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients
    Reem Karmali
    Division of Hematology Oncology Cell Therapy, Rush University Medical Center, 1725 W Harrison St, Chicago, IL 60612, USA
    J Leukoc Biol 93:161-70. 2013
    ..This suggests utility in detecting disease progression early, identifying those likely to incur a survival advantage with early treatment, and directing future therapy...
  6. ncbi request reprint Posttransplant lymphoproliferative disorder: extranodal marginal zone lymphoma occurring after renal transplantation
    Justin M Goldfarb
    Section of Hematology and Oncology, Rush University Medical Center, Chicago, IL 60612, USA
    Clin Adv Hematol Oncol 4:600-4; discussion 604-6. 2006